Anti-MDM2 antibody conjugated liposomes hold significant potential in pancreatic cancer research by enhancing targeted delivery of therapeutic agents to tumor cells. By specifically binding to MDM2, which is often overexpressed in pancreatic tumors, these liposomes can facilitate precise drug release at the site of action, thereby minimizing systemic toxicity. Additionally, this targeted approach may help overcome the challenges associated with the dense stroma commonly found in pancreatic cancer, improving drug penetration and efficacy. Ultimately, the use of these conjugated liposomes could lead to more effective treatment strategies that improve patient outcomes in this aggressive cancer type.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-648 | Recombinant Anti-human MDM2 Antibody | ELISA, WB, IF, FuncS | IgG |
ZG-0396U | Rabbit Anti-MDM2 Recombinant Antibody (clone E22-L) | IHC-P | Rabbit IgG |
VS3-WK838 | Mouse Anti-MDM2 Recombinant Antibody (VS3-WK838) | WB | Mouse IgG |
VS3-WK2178 | Rabbit Anti-MDM2 (pY394) Recombinant Antibody (VS3-WK2178) | WB, ELISA | Rabbit IgG |
VS3-WK2255 | Rabbit Anti-MDM2 (pS166) Recombinant Antibody (VS3-WK2255) | WB, IHC | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY230. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.